SironRX Therapeutics, Inc. — Form D/A
SironRX Therapeutics, Inc. of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2011-08-18. The offering totals $3.4M, of which $3.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2011-08-18
- Form: D/A
- Accession: 0001520621-11-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $3.4M
- Amount sold: $3.4M
- Minimum investment: $10K
- Investors: 53
- Date of first sale: 2011-04-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-159694
Issuer
- Name: SironRX Therapeutics, Inc.
- CIK: 0001520621
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 10000 CEDAR ROAD, CLEVELAND, OH, 44106
- Phone: 216-445-0830
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Rahul Aras | Director | Cleveland, OH |
| Mike Bunker | Director | Cleveland, OH |
| George Emont | Director | Cleveland, OH |
| Linda Tufts | Director | Cleveland, OH |
| Rahul Aras | Executive Officer | Cleveland, OH |
| Mike Bunker | Executive Officer | Cleveland, OH |
Other filings by this issuer (1)
More